Author Page for Shinsuke Toba

Actions:

View:
Selected
Original List
All Versions Hide All Versions
All Abstracts Hide All Abstracts

(Rank)

In vivo antiviral efficacy and safety of 5-hydroxymethyltubercidin against DENV2 and SARS-CoV-2

Number of pages: 21 Posted: 25 Apr 2026

Kentaro Uemura, Shinsuke Toba, Shinji Kusakabe, Michihito Sasaki, Yasuko Orba, Naoyoshi Maeda, Mayumi Ishii, Kayoko Kanamitsu, Hirofumi Sawa, Akira Matsuda, Akihiko Sato and Katsumi Maenaka

Shionogi & Co. Ltd. - Shionogi Pharmaceutical Research Center, Shionogi & Co. Ltd. - Shionogi Pharmaceutical Research Center, affiliation not provided to SSRN, Hokkaido University - Division of Molecular Pathobiology, Hokkaido University - Division of Molecular Pathobiology, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Hokkaido University, Hokkaido University, Hokkaido University - Division of Molecular Pathobiology and Hokkaido University - Laboratory of Biomolecular Science

Downloads 21 (1,448,301)

Shinsuke Toba

Shionogi & Co. Ltd. - Shionogi Pharmaceutical Research Center

1

21

0

Scholarly Papers (1)

In vivo antiviral efficacy and safety of 5-hydroxymethyltubercidin against DENV2 and SARS-CoV-2

Abstract:

Shinsuke Toba

Shionogi & Co. Ltd. - Shionogi Pharmaceutical Research Center

1

21

0

Scholarly Papers (1)

​In vivo antiviral efficacy and safety of 5-hydroxymethyltubercidin against DENV2 and SARS-CoV-2​

Abstract:

In vivo antiviral efficacy and safety of 5-hydroxymethyltubercidin against DENV2 and SARS-CoV-2